| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Century Therapeutics, Inc. | President of R&D | Common Stock | 536,544 | $2,757,622 | $5.14 | 07 Mar 2024 | By Irrevocable Spousal Trust for Rhonda L. Zuckerman |
| Century Therapeutics, Inc. | President of R&D | Common Stock | 24,000 | $123,350 | $5.14 | 07 Mar 2024 | Direct |
| Century Therapeutics, Inc. | President of R&D | Stock Option (right to buy) | 146,000 | 07 Mar 2024 | Direct | ||
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 32,000 | 01 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | 01 Apr 2024 | 1 | $0 | 4 | Director | 03 Apr 2024, 20:00 |
| IPSC | Century Therapeutics, Inc. | 07 Mar 2024 | 2 | $0 | 4 | President of R&D | 11 Mar 2024, 19:34 |
| IPSC | Century Therapeutics, Inc. | 12 Apr 2023 | 1 | $0 | 4 | President of R&D | 14 Apr 2023, 19:56 |
| IPSC | Century Therapeutics, Inc. | 12 Apr 2023 | 0 | $0 | 3 | President of R&D | 14 Apr 2023, 19:55 |
| REPL | Replimune Group, Inc. | 01 Apr 2023 | 1 | $0 | 4 | Director | 04 Apr 2023, 20:03 |
| REPL | Replimune Group, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 16:08 |
| IPSC | Century Therapeutics, Inc. | 25 Jan 2022 | 1 | $0 | 4 | President of R&D | 27 Jan 2022, 15:50 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | President of R&D | 17 Jun 2021, 16:59 |